Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation

NCT01066689 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Graft Rejection

Interventions

DRUG: MabThera
DRUG: Physiological serum (Sodium Chloride, sodium citrate)

Sponsor

University Hospital, Tours

Collaborators

[object Object]